Department of Colorectal Surgery, Pôle des Maladies de l'Appareil Digestif (PMAD), Beaujon Hospital (AP-HP), Clichy, France.
Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x.
This study aimed to develop a new model of colorectal liver metastases (LM) in the rat. Both single macroscopic and multiple bilobar microscopic LM were investigated, as this closely resembled the human situation, before right hepatectomy was performed for 'single' right LM. The single macroscopic LM was elicited by direct injection of DHD/K12 colorectal cancer cells under the capsule of the median liver lobe in immunocompetent BDIX rats. The bilobar micrometastases were elicited by intraportal injection of DHD/K12 cells. A preliminary protocol was conducted to assess the dose of cells required to inject in to the portal vein, using 10(6) , 2 × 10(6) and 3 × 10(6) DHD/K12 cells (n = 15 rats). The resultant protocol for the experimental model used intraportal injection of 10(6) DHD/K12 cells and direct injections of 0.5 × 10(6) , 10(6) and 1.5 × 10(6) DHD/K12 cells (n = 15 rats). For both protocols, BDIX rats were sacrificed at day 30 after injection. The preliminary protocol showed that intraportal injection of 10(6) DHD/K12 cells was associated with bilobar micrometastases of 0.8 mm mean diameter at day 30. The main protocol assessed that direct injection of 0.5 × 10(6) under the liver median lobe capsule and intraportal injection of 10(6) DHD/K12 cells were associated at day 30 with a single macroscopic metastasis confined to a liver lobe and bilobar micrometastases, without peritoneal carcinomatosis or lung metastasis. Thus we have developed a new experimental model of bilobar colorectal LM including both macro- and microscopic colorectal LMs, which mimics the human situation and which will be useful in preclinical studies.
本研究旨在建立一种新的大鼠结直肠癌肝转移(LM)模型。在进行右半肝切除术治疗“单发”右 LM 之前,我们同时研究了单发的大 LM 和多发的双侧小 LM,因为这更接近人类的情况。免疫功能正常的 BDIX 大鼠通过在肝中叶包膜下直接注射 DHD/K12 结直肠癌细胞来诱发单发大 LM。通过门静脉内注射 DHD/K12 细胞来诱发双侧微转移。我们进行了一项初步方案来评估门静脉内注射细胞所需的剂量,使用了 10(6)、2×10(6)和 3×10(6)个 DHD/K12 细胞(n=15 只大鼠)。实验模型的最终方案采用门静脉内注射 10(6)个 DHD/K12 细胞,以及直接注射 0.5×10(6)、10(6)和 1.5×10(6)个 DHD/K12 细胞(n=15 只大鼠)。对于这两种方案,BDIX 大鼠在注射后第 30 天被处死。初步方案显示,门静脉内注射 10(6)个 DHD/K12 细胞与第 30 天的双侧微转移有关,微转移的平均直径为 0.8 毫米。主要方案评估了在肝中叶包膜下直接注射 0.5×10(6)个细胞和门静脉内注射 10(6)个 DHD/K12 细胞,与第 30 天时局限于一叶的单发大转移和双侧微转移相关,无腹膜癌病或肺转移。因此,我们建立了一种新的结直肠癌双侧 LM 实验模型,包括大 LM 和小 LM,该模型模拟了人类情况,将有助于临床前研究。